Alfredo
García Layana
Catedrático de Universidad
Hospital Miguel Servet
Zaragoza, EspañaPublicaciones en colaboración con investigadores/as de Hospital Miguel Servet (9)
2024
-
Assessing the economic burden of vision loss and irreversible legal blindness in Spain (2021–2030): a societal perspective
Health Economics Review, Vol. 14, Núm. 1
-
Macular Neovascularization Type Influence on Anti-VEGF Intravitreal Therapy Outcomes in Age-Related Macular Degeneration
Ophthalmology Retina, Vol. 8, Núm. 4, pp. 350-359
-
Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical Practice
Ophthalmology and Therapy
2022
-
Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomes
Clinical and Experimental Ophthalmology, Vol. 50, Núm. 3, pp. 312-324
-
Incidence, Risk Factors, and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-VEGF for Retinal Diseases: Data from the Fight Retinal Blindness! Registry
Ophthalmology Retina, Vol. 6, Núm. 11, pp. 1044-1053
-
The role of retinal fluid location in atrophy and fibrosis evolution of patients with neovascular age-related macular degeneration long-term treated in real world
Acta ophthalmologica, Vol. 100, Núm. 2, pp. e521-e531
2021
-
A randomized study of nutritional supplementation in patients with unilateral wet age-related macular degeneration
Nutrients, Vol. 13, Núm. 4
-
Recommendations for ophthalmologic practice during the easing of COVID-19 control measures
Acta Ophthalmologica, Vol. 99, Núm. 7, pp. e973-e983